Skip to main content
. 2019 Feb 11;20(3):759. doi: 10.3390/ijms20030759

Table 2.

In vivo effects of insulin receptor (INSR) and insulin-like growth factor-I receptor (IGF-IR) deletion in AT.

References Mice Model Vector Location of Deletion Effects
[82,106] FIRKO aP2/Cre aP2 expressing cells Fat mass (↓)
Glucose transport (↓)
Suppression of lipolysis
Lifespan (↑)
[107] GIRKO GLUT4/Cre GLUT4 expressing tissues Diabetes
Insulin-resistant AT
Heterogeneous WAT
[108,109] AIRKO Adiponectin/Cre Adiponectin expressing cells Lipodystrophy
IR
IFG
Dyslipidemia
FLD
Lifespan (↓)
[110] AIRKO Adiponectin/Cre + tamoxifen Adiponectin expressing cells WAT (↓)
BAT (↓)
Metabolic syndrome
AT regeneration after 30 days
[111] PerIRKO Cre-ER + tamoxifen Liver, WAT,
skeletal muscle
Diabetes
Lifespan (↓)
[112] IGF-IRKO Not available Immortalized fetal
brown adipocytes
Death (↑)
Survival (↓)
[113] F-IR/IGFRKO UCP1/Cre BAT BAT atrophy
Impaired thermogenesis
Mitochondrial dysfunction
Body fat mass (↑)
IR (↑)
Susceptibility to obesity
[30] F-IR/IGFRKO aP2/Cre aP2 expressing cells WAT (↓)
BAT (↓)
Impaired thermogenesis
Energy expenditure (↑)
[108] F-IR/IGFRKO Adiponectin/Cre Adiponectin expressing cells WAT (↓)
BAT (↓)
Impaired thermogenesis
Severe diabetes
Ectopic lipid accumulation in liver, muscle and pancreatic islets

↓, decrease; ↑, increase; AT, adipose tissue; AIRKO, adipocyte-specific insulin receptor knockout; aP2, fatty acids binding protein; BAT, brown adipose tissue; Cre, recombinase cre; ER, estrogen receptor; FIRKO, fat-specific insulin receptor knockout; F-IR/IGFRKO, insulin receptor/IGF-IR double knockout; FLD, fatty liver disease; GIRKO, GLUT4-specific insulin receptor knockout; GLUT4, glucose transporter 4; IFG, impaired fasting glucose; IGF-IRKO, IGF-IR knockout; IR, insulin resistance; PerIRKO, peripheral insulin receptor knockout; WAT, white adipose tissue; UCP1, uncoupling protein 1.